Methods for drug discovery, disease treatment, and diagnosis using metabolomics
DCFirst Claim
Patent Images
1. A method for metabolomically identifying small molecules indicative of amyotrophic lateral sclerosis, comprising:
- obtaining a small molecule profile from a subject suffering from amyotrophic lateral sclerosis; and
comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of amyotrophic lateral sclerosis, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.
9 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy of drugs are also discussed.
114 Citations
78 Claims
-
1. A method for metabolomically identifying small molecules indicative of amyotrophic lateral sclerosis, comprising:
-
obtaining a small molecule profile from a subject suffering from amyotrophic lateral sclerosis; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of amyotrophic lateral sclerosis, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (2, 3, 4, 10, 31, 32, 33, 34, 35, 36, 37, 38)
-
-
5. A method for metabolomically identifying small molecules indicative of Parkinson'"'"'s disease, comprising:
-
obtaining a small molecule profile from a subject suffering from Parkinson'"'"'s disease; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of Parkinson'"'"'s disease, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (11, 12, 13, 14, 39, 40, 41, 42, 43, 44, 45, 46)
-
-
6. A method for metabolomically identifying small molecules indicative of schizophrenia, comprising:
-
obtaining a small molecule profile from a subject suffering from schizophrenia; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of schizophrenia, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (15, 16, 17, 18, 47, 48, 49, 50, 51, 52, 53, 54)
-
-
7. A method for metabolomically identifying small molecules indicative of Parkinson'"'"'s disease, comprising:
-
obtaining a small molecule profile from a subject suffering from Parkinson'"'"'s disease; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of Parkinson'"'"'s disease, wherein small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (19, 20, 21, 22, 55, 56, 57, 58, 59, 60, 61, 62)
-
-
8. A method for metabolomically identifying small molecules indicative of depression, comprising:
-
obtaining a small molecule profile from a subject suffering from depression; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of depression, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (23, 24, 25, 26, 63, 64, 65, 66, 67, 68, 69, 70)
-
-
9. A method for metabolomically identifying small molecules indicative of schizophrenia, comprising:
-
obtaining a small molecule profile from a subject suffering from schizophrenia; and comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of schizophrenia, wherein small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample. - View Dependent Claims (27, 28, 29, 30, 71, 72, 73, 74, 75, 76, 77, 78)
-
Specification